Cargando…

Patients’ health literacy in psychotic disorders

Compliance and relapse are major issues in the treatment of psychotic disorders. About 50% of subjects with schizophrenia do not comply with treatment and relapse rates of 65% are reported after one year and 80% after two years. Drug treatments are effective against psychotic symptoms, but cannot pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Saba, Ghassen, Mékaoui, Lila, Leboyer, Marion, Schürhoff, Franck
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2655084/
https://www.ncbi.nlm.nih.gov/pubmed/19300580
_version_ 1782165434960707584
author Saba, Ghassen
Mékaoui, Lila
Leboyer, Marion
Schürhoff, Franck
author_facet Saba, Ghassen
Mékaoui, Lila
Leboyer, Marion
Schürhoff, Franck
author_sort Saba, Ghassen
collection PubMed
description Compliance and relapse are major issues in the treatment of psychotic disorders. About 50% of subjects with schizophrenia do not comply with treatment and relapse rates of 65% are reported after one year and 80% after two years. Drug treatments are effective against psychotic symptoms, but cannot promote functional recovery or prevent relapses when prescribed alone. The factors influencing compliance include side effects and the patients’ awareness of their illness. Psychosocial interventions, cognitive remediation and psychotherapy have been proposed as adjuvant treatments to increase compliance and to decrease the rate of relapse. Most of these interventions have been shown to increase compliance and to decrease the rate of relapse, but the most robust results have been achieved with cognitive behavioral therapy.
format Text
id pubmed-2655084
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-26550842009-03-19 Patients’ health literacy in psychotic disorders Saba, Ghassen Mékaoui, Lila Leboyer, Marion Schürhoff, Franck Neuropsychiatr Dis Treat Original Research Compliance and relapse are major issues in the treatment of psychotic disorders. About 50% of subjects with schizophrenia do not comply with treatment and relapse rates of 65% are reported after one year and 80% after two years. Drug treatments are effective against psychotic symptoms, but cannot promote functional recovery or prevent relapses when prescribed alone. The factors influencing compliance include side effects and the patients’ awareness of their illness. Psychosocial interventions, cognitive remediation and psychotherapy have been proposed as adjuvant treatments to increase compliance and to decrease the rate of relapse. Most of these interventions have been shown to increase compliance and to decrease the rate of relapse, but the most robust results have been achieved with cognitive behavioral therapy. Dove Medical Press 2007-08 /pmc/articles/PMC2655084/ /pubmed/19300580 Text en © 2007 Dove Medical Press Limited. All rights reserved
spellingShingle Original Research
Saba, Ghassen
Mékaoui, Lila
Leboyer, Marion
Schürhoff, Franck
Patients’ health literacy in psychotic disorders
title Patients’ health literacy in psychotic disorders
title_full Patients’ health literacy in psychotic disorders
title_fullStr Patients’ health literacy in psychotic disorders
title_full_unstemmed Patients’ health literacy in psychotic disorders
title_short Patients’ health literacy in psychotic disorders
title_sort patients’ health literacy in psychotic disorders
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2655084/
https://www.ncbi.nlm.nih.gov/pubmed/19300580
work_keys_str_mv AT sabaghassen patientshealthliteracyinpsychoticdisorders
AT mekaouilila patientshealthliteracyinpsychoticdisorders
AT leboyermarion patientshealthliteracyinpsychoticdisorders
AT schurhofffranck patientshealthliteracyinpsychoticdisorders